tiprankstipranks
Microbix Biosystms J (TSE:MBX)
TSX:MBX
Canadian Market
Holding TSE:MBX?
Track your performance easily

Microbix Biosystms (MBX) Earnings Dates, Call Summary & Reports

30 Followers

Earnings Data

Report Date
Feb 12, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
Last Year’s EPS
0.02
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:May 13, 2019
|
% Change Since: 22.22%
|
Next Earnings Date:Feb 12, 2019
Earnings Call Sentiment|Positive
Microbix reported a strong fiscal year with record revenue growth and improved margins. Strategic investments and share repurchases were highlighted, along with operational expansions. The Kinlytic project is progressing well, with no major challenges reported. However, there is some concern about potential U.S. tariffs. The overall sentiment of the call is optimistic, focusing on continued growth and expansion.
Company Guidance
The recent earnings call for Microbix Biotechnologies Inc. (MBX.TO) highlighted a successful fiscal year 2024, characterized by a 40% growth in ongoing sales, reaching $25.4 million in revenues, compared to 2023. The company managed to achieve a compound annual growth rate (CAGR) of 20% to 40%, outperforming the industry average of 5% to 10%. Their antigen business grew by 44%, while the QAPs segment increased by 38%. Microbix also reported record Q4 revenue of $6.3 million, up 48% from the previous year, and maintained strong operational control with a 55% margin and 18% EBITDA for the quarter. The company repurchased over 2% of its shares, contributing to an anti-dilutive position. Looking ahead, Microbix aims to sustain its revenue growth, improve gross margins, and leverage its operational excellence to tap into new markets, including genetics testing and oncology, while maintaining a target gross margin of around 60%. They also plan to continue strategic reinvestments, with a projected capital expenditure of over $2 million in 2025.
Record Revenue Growth
Q4 revenue reached $6.3 million, marking a 48% increase from the previous year. Annual revenue was $25.4 million, reflecting a 40% growth, with antigens up 44% and QAPs up 38%.
Strong Financial Performance
The company reported a 55% margin for Q4 and an 18% EBITDA. On an annual basis, margins increased to 53% from 40% last year.
Strategic Investments and Share Repurchases
Over $2 million was invested in facilities and equipment, and 2.6 million shares were repurchased, stabilizing the share price.
Operational Excellence and Capacity Building
New facilities and a lab were opened, supported by federal and provincial grants, and an electronic quality management system was implemented.
Kinlytic Progress
Recognition of $3 million in Kinlytic milestone payments contributed to the fiscal year performance. The project is on track for 2027.
---

Microbix Biosystms (TSE:MBX) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

TSE:MBX Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 12, 20192019 (Q1)
- / >-0.01
-0.0010.00% (0.00)
May 13, 20192019 (Q2)
- / <0.01
-0.004200.00% (<+0.01)
Aug 12, 20192019 (Q3)
- / >-0.01
0
Dec 20, 20192019 (Q4)
- / 0.00
-0.084
Feb 13, 20202020 (Q1)
- / >-0.01
-0.001-500.00% (>-0.01)
May 14, 20202020 (Q2)
- / >-0.01
0.004-150.00% (>-0.01)
Aug 14, 20202020 (Q3)
- / >-0.01
-0.002-100.00% (>-0.01)
Dec 18, 20202020 (Q4)
- / -0.05
0
Feb 11, 20212021 (Q1)
- / <0.01
-0.006116.67% (<+0.01)
May 13, 20212021 (Q2)
0.00 / <0.01
-0.002450.00% (<+0.01)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

TSE:MBX Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Dec 19, 2024C$0.36C$0.37+2.78%
Aug 14, 2024C$0.34C$0.340.00%
May 15, 2024C$0.32C$0.35+9.37%
Feb 14, 2024C$0.40C$0.42+5.00%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Microbix Biosystms J (TSE:MBX) report earnings?
Microbix Biosystms J (TSE:MBX) is schdueled to report earning on Feb 12, 2025, TBA Not Confirmed.
    What is Microbix Biosystms J (TSE:MBX) earnings time?
    Microbix Biosystms J (TSE:MBX) earnings time is at Feb 12, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is TSE:MBX EPS forecast?
          Currently, no data Available
          ---
          What am I Missing?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis